Radiomics Signature: A potential biomarker for the prediction of survival in Advanced Hepatocellular Carcinoma

Objectives: To develop and validate radiomics nomograms for the pretreatment predictions of overall survival (OS) and time to progression (TTP) in the patients with advanced hepatocellular carcinoma (HCC) treated with apatinib plus transarterial chemoembolization (TACE), and to assess the incrementa...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lingli, Kan, Xuefeng, Zhao, Yongjun, Liang, Bo, Ye, Tianhe, Yang, Lian, Zheng, Chuansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100633/
https://www.ncbi.nlm.nih.gov/pubmed/33967603
http://dx.doi.org/10.7150/ijms.55510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100633/
https://www.ncbi.nlm.nih.gov/pubmed/33967603
http://dx.doi.org/10.7150/ijms.55510

Ejemplares similares